HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421

MBL Life Sciences

Catalog No.: MBL-TC-0167-4

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: BV421
• Immunogen: LY6K
• Peptide Sequence: RYCNLEGPPI
• Class: Class I
• Sequence Location: 177-186
• MHC Allele: A*24:02